GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion Ruchika Sharma15 May 2025 4:10 PM ISTLondon: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies for patients with...
GSK, partner iTeos end development programme for lung cancer drug belrestotug Ruchika Sharma14 May 2025 2:30 PM ISTGSK plc with its development partner iTeos Therapeutics, Inc., has announced that it is ending the development programme for experimental lung cancer...
GSK Blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma Ruchika Sharma20 April 2025 10:00 AM ISTGSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, Blenrep is...
GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices Ruchika Sharma20 April 2025 9:00 AM ISTGSK plc has announced that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including...
GSK in breach for misleading prescription information on Omjjara: industry body Ruchika Sharma16 April 2025 2:34 PM ISTLondon: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards in the marketing and...
GSK, Pfizer resolve patent lawsuit over RSV vaccines Ruchika Sharma8 April 2025 5:10 PM ISTPfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV)...
FDA Approves Gepotidacin for Uncomplicated UTIs Dr. Kamal Kant Kohli26 March 2025 8:45 PM ISTThe FDA has approved GSK's gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged 12 and older. The...
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older Ruchika Sharma26 March 2025 11:15 AM ISTLondon: GSK plc has announced that the Company has received US Food and Drug Administration (FDA) approval for Blujepa (gepotidacin) for the...
GSK application to expand use of Nucala for COPD accepted for review by EMA Ruchika Sharma25 March 2025 1:30 PM ISTIL-5 is a key cytokine (protein) in type 2 inflammation which is an underlying driver in many diseases.
Pfizer to exit Haleon Ruchika Sharma19 March 2025 6:30 PM ISTBengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group.As part of the...
GSK Pharma names Carson Dalton as Executive Vice President, Communications and Government Affairs Ruchika Sharma4 March 2025 3:12 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Carson Dalton as Executive Vice President, Communications...
USFDA accepts GSK depemokimab applications for review for asthma, chronic rhinosinusitis Ruchika Sharma4 March 2025 12:30 PM ISTLondon: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License Application for the use of...
